177 related articles for article (PubMed ID: 35903153)
1. Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer.
Lan T; Wang Y; Miao J; Guo H; Wang Z; Wang J; Zhang C; Yang P; Zhang Z; Dunmall LC; Wang Y
Front Mol Biosci; 2022; 9():887059. PubMed ID: 35903153
[No Abstract] [Full Text] [Related]
2. Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors.
Zhao H; Xie R; Zhang C; Lu G; Kong H
Front Genet; 2022; 13():989460. PubMed ID: 36159971
[No Abstract] [Full Text] [Related]
3. Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma.
Chen X; Yuan Y; Zhou F; Huang X; Pu J; Niu X; Jiang X; Ding X
Aging (Albany NY); 2022 Sep; 14(19):7866-7876. PubMed ID: 36170019
[TBL] [Abstract][Full Text] [Related]
4. Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration.
Bao W; Yang H; Zhou S; Huang F; Wei Z; Peng Z
J Gastrointest Oncol; 2023 Jun; 14(3):1546-1559. PubMed ID: 37435228
[TBL] [Abstract][Full Text] [Related]
5. DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma.
Guo Y; Luo W; Huang S; Zhao W; Chen H; Ma Y; Ye M; Nie Y; Zhang Y; Huang C; Zhou Q; He X; Chen M
J Hepatocell Carcinoma; 2021; 8():871-885. PubMed ID: 34377684
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of deoxythymidylate kinase suppresses progression and epithelial-mesenchymal-transition of lung adenocarcinoma via STAT3 signaling.
Yu F; Chen Y; Qiu R; Lin N; Yin Y; Zhuo Y; Lin J; Lai F
Physiol Genomics; 2023 May; 55(5):213-221. PubMed ID: 36939206
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
Han X; Long W; Liu Y; Xu J
Front Surg; 2022; 9():985034. PubMed ID: 36338652
[TBL] [Abstract][Full Text] [Related]
8. The Impact of DTYMK as a Prognostic Marker in Colorectal Cancer.
Aloliqi AA; Fararjeh AF; Al-Khader A; Kaddumi E; Eisa AA; Jaradat W
World J Oncol; 2023 Feb; 14(1):84-93. PubMed ID: 36895992
[TBL] [Abstract][Full Text] [Related]
9. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker.
Shen X; Mo X; Tan W; Mo X; Li L; Yu F; He J; Deng Z; Xing S; Chen Z; Yang J
Pathol Oncol Res; 2022; 28():1610754. PubMed ID: 36419650
[No Abstract] [Full Text] [Related]
10. The Prognostic Significance of
Li Z; Cui Y; Duan Q; Zhang J; Shao D; Cao X; Gao Y; Wang S; Li J; Jones OD; Lei X; Wang L; Zhou X; Xu M; Ma J; Liu Y; Xu X
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361587
[TBL] [Abstract][Full Text] [Related]
11.
Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma.
Zhang Y; Wang H; Liu Y; Yang J; Zuo X; Dong M; Zhang Z; Shi Y; Deng X; Lv Y
Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36094557
[TBL] [Abstract][Full Text] [Related]
13. The evolving landscape of involvement of DTYMK enzymes in cancer.
Heydari N; Mahdizadeh M; Jafari SM
Med Oncol; 2023 Jun; 40(8):213. PubMed ID: 37358701
[TBL] [Abstract][Full Text] [Related]
14. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
[TBL] [Abstract][Full Text] [Related]
15. TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma.
Xiao X; Shan H; Niu Y; Wang P; Li D; Zhang Y; Wang J; Wu Y; Jiang H
Front Mol Biosci; 2022; 9():647826. PubMed ID: 35558557
[TBL] [Abstract][Full Text] [Related]
16. Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker.
Feng Z; Chen Y; Cai C; Tan J; Liu P; Chen Y; Shen H; Zeng S; Han Y
Front Immunol; 2022; 13():916594. PubMed ID: 35844598
[TBL] [Abstract][Full Text] [Related]
17. ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC.
Zhou L; Fu Z; Wang S; Jia J; Cheng Y; Zheng Y; Zhang N; Lu W; Yao Z
Front Oncol; 2022; 12():875097. PubMed ID: 35586489
[TBL] [Abstract][Full Text] [Related]
18. Integrative Multi-Omics Analysis of Identified Ferroptosis-Marker RPL8 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Liver Cancer.
Fan S; Zhang S; Kong D; Wang H; Shi Y; Wang Z; Zheng H
Comb Chem High Throughput Screen; 2023; 26(7):1298-1310. PubMed ID: 36017842
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Immunological Role of FUN14 Domain Containing 1 in Pan-Cancer: Friend or Foe?
Yuan Q; Sun N; Zheng J; Wang Y; Yan X; Mai W; Liao Y; Chen X
Front Oncol; 2019; 9():1502. PubMed ID: 31998650
[No Abstract] [Full Text] [Related]
20. Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin.
Sun F; Liu Y; Gong T; Pan Q; Xiang T; Zhao J; Tang Y; Chen H; Han Y; Song M; Huang Y; Li H; Chen Y; Yang C; Yang J; Wang Q; Li Y; He J; Weng D; Peng R; Xia J
Cell Death Dis; 2021 Nov; 12(12):1093. PubMed ID: 34795209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
